Biopsy or biomarkers: Is there a gold standard for diagnosis of liver fibrosis?

被引：53

作者：

Afdhal, NH ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Liver Ctr, Boston, MA 02125 USA

来源：

CLINICAL CHEMISTRY | 2004年 / 50卷 / 08期

关键词：

D O I：

10.1373/clinchem.2004.035899

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1299 / 1300

页数：2

共 8 条

[1] Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests? [J].

Afdhal, NH .

HEPATOLOGY, 2003, 37 (05) :972-974

[2]

AFDHAL NH, 2004, IN PRESS AM J GASTRO

[3] Sampling variability of liver fibrosis in chronic hepatitis C [J].

Bedossa, P ;

Dargère, D ;

Paradis, V .

HEPATOLOGY, 2003, 38 (06) :1449-1457

[4] Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors [J].

Imbert-Bismut, F ;

Messous, D ;

Thibaut, V ;

Myers, RB ;

Piton, A ;

Thabut, D ;

Devers, L ;

Hainque, B ;

Mercadier, A ;

Poynard, T .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (03) :323-333

[5] Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study [J].

Imbert-Bismut, F ;

Ratziu, V ;

Pieroni, L ;

Charlotte, F ;

Benhamou, Y ;

Poynard, T .

LANCET, 2001, 357 (9262) :1069-1075

[6] Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C [J].

Poynard, T ;

Munteanu, M ;

Imbert-Bismut, F ;

Charlotte, F ;

Thabut, D ;

Le Calvez, S ;

Messous, D ;

Thibault, V ;

Benhamou, Y ;

Moussalli, J ;

Ratziu, V .

CLINICAL CHEMISTRY, 2004, 50 (08) :1344-1355

[7] Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin [J].

Poynard, T ;

McHutchison, J ;

Manns, M ;

Myers, RP ;

Albrecht, J .

HEPATOLOGY, 2003, 38 (02) :481-492

[8]

Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x

← 1 →